Efficacy and safety of belimumab combined with standard regimen in the treatment of active lupus nephritis

Dongming Wu, Yimamuyushan Aikeda, Yu Jiang, Yuying Ouyang, Bin Li, Jianbo Li, Jianwen Yu, Xunhua Zheng, Fengxian Huang, Wei Chen, Qinghua Liu

PDF(689 KB)
Chinese Journal of Nephrology
Chinese Journal of Nephrology ›› 2023, Vol. 39 ›› Issue (4) : 245-252. DOI: 10.3760/cma.j.cn441217-20221108-01113
Clinical Study

Efficacy and safety of belimumab combined with standard regimen in the treatment of active lupus nephritis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 39(4): 245-252. DOI: 10.3760/cma.j.cn441217-20221108-01113.

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(689 KB)

Accesses

Citation

Detail
Sections
Recommended

Copyright© by the Editorial Board of Chinese Journal of Nephrology, Chinese Medical Association and the First Affiliated Hospital of Sun Yat-sen University (Guangzhou) Journal Co., Ltd

Address: Floor 2, Longzhu building, No. 5, Zhusigang Second Road, Yuexiu District, Guangzhou (510080) Tel：(020)87331532　Email：cmaszb@mail.sysu.edu.cn

This system is designed and developed by Beijing magtec Technology Development Co., Ltd. with technical support: support@magtech.com.cn

粤ICP备10090623号

/

〈 〉